Back
Speaker illustration

Miss Christina Maria Toferer

Graz (Austria)

Presentations

Prognostic impact of SGLT2-inhibitor therapy on survival in patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Cardiac amyloidosis: diagnosis and outcomes

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources